Top 10 eurekatherapeutics.com Wettbewerber

corvuspharma.com

corvus pharmaceuticals is a clinical science-driven biopharmaceutical company focused on the development of cleverly-designed medicines with precise mechanisms of action to improve the lives of patients with the most difficult-to-treat cancers.

titanpharm.com

Titan Pharmaceuticals, Inc. - Privacy Policy

astellasgenetherapies.com

Gene Therapy Company | Rare Genetic Disease

mbcbiolabs.com

December 14, 2017 1. HPLC Products 2. Business Development and Venture Investment Our newest sponsor Tosoh will be here on December 14th. Amongst Tosoh's interests is the Separations and Purification Division.  Their scientist, Philip Hoang, will be here and would be happy to meet with you to

aligos.com

Aligos is dedicated to developing potential new treatments for serious and life-threatening diseases. To accomplish this goal, we must utilize our resources efficiently to focus on advancing our investigational products through the clinical development process. In this way, we are currently prioritizing enrolling and conducting the clinical trials necessary to generate data sufficient to apply […]

nurixtx.com

Browse current openings at Nurix across research, clinical, and business roles. Find your next opportunity. We'd love to hear from you.

theravance.com

View open positions for creative problems solvers who thrive on applying insight and innovation to discovering and advancing novel medicines. Join the team.

alxoncology.com

We’re dedicated to expanding the possibilities for patients by developing novel approaches to optimize current and future standards of care.

nektar.com

Contact Nektar for partnerships, careers, investor relations, media, clinical trial information, and more.

sutrobio.com

sutro biopharma, inc. is a public biotechnology company headquartered in south san francisco, california focused on clinical stage drug discovery, development and manufacturing company. using its integrated cell-free protein synthesis platform, xpresscf, to create a variety of protein therapeutics for cancer and autoimmune disorders. it focuses to design therapeutics using potent modalities, including cytokine based immune-oncology (i/o) therapeutics, antibody-drug conjugates (adcs) and bispecific antibodies that are directed primarily against clinically validated targets. its product candidates include stro-001 and stro-002. stro-001 is an adc directed against the cancer target cd74, for patients with multiple myeloma and non-hodgkin lymphoma (nhl). stro-002 is an adc directed against folate receptor-alpha (folra), for patients with ovarian and endometrial cancers. stro-001 and stro-002 are designed and optimized for therapeutic index by placing linker-warheads at specific locations within the antibody using its xpresscf platform.